HT5
SWX:HT5
CHF 2,95
+ CHF0,13 (4,61%)
2,95 CHF
+CHF0,13 (4,61%)
End-of-day quote: 03/27/2026

HT5 Stock Value

The current analyst rating for HT5 is sf_Data Unavailable.
-

HT5 Company Info

EPS Growth 5Y
15,12%
Market Cap
CHF0,05 B
Long-Term Debt
CHF0,07 B
Annual earnings
N/A
Dividend
CHF0,00
Dividend Yield
0,00%
Founded
1895
Industry
Website
HT5
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, HT5’s Price Target has risen from CHF1,13 to CHF1,13 - a 0,00% increase. One analysts predict that HT5’s share price will fall in the coming year, reaching CHF0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

What does HT5 do?

HT5 AG does not have significant operations. The year 2024 marks a significant turning point of the the company. The sale of HOCHDORF Swiss Nutrition Ltd. to Freienbach-based Figaro BidCO Ltd., a member of the as Equity Partners Group, on December 10, 2024, enabled the continued operation of the business and enabled HOCHDORF Swiss Nutrition Ltd. to take the step toward an independent future. The company was engaged in its two business areas, Food Solutions and Infant Nutrition. While sales in...
×